| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |